Férézou J, Coste T, Chevallier F
Digestion. 1981;21(5):232-43. doi: 10.1159/000198568.
An experimental procedure using stable isotope-labeled cholesterol (13C and D) was carried out on 15 healthy subjects to distinguish the different origins of neutral fecal sterols in man: nonabsorption of dietary cholesterol, fecal excretion by transfer of plasmatic cholesterol and external secretion of cholesterol biosynthetized in digestive tract and directly eliminated. For a mean daily mass of 652 mg of fecal cholesterol, unabsorbed dietary cholesterol is 20% (133 mg), excreted cholesterol 67% (434 mg) and cholesterol from external secretion 13% (85 mg). A short treatment (4 days) with cholestyramine or different bile acids was then administered to each subject to study the possible variations in their fecal elimination of cholesterol. The more evident effect was the large stimulation of external secretion of cholesterol (234 mg/day) observed after chenodeoxycholic acid feeding (1 g/day). This treatment tends also to decrease dietary cholesterol absorption and to enhance excretion of cholesterol.
对15名健康受试者进行了一项使用稳定同位素标记胆固醇(13C和D)的实验程序,以区分人类中性粪便固醇的不同来源:膳食胆固醇未吸收、血浆胆固醇转移导致的粪便排泄以及消化道中生物合成并直接排出的胆固醇的外分泌。对于平均每日粪便胆固醇量为652毫克,未吸收的膳食胆固醇占20%(133毫克),排泄胆固醇占67%(434毫克),外分泌胆固醇占13%(85毫克)。然后对每位受试者进行短期治疗(4天),使用消胆胺或不同的胆汁酸,以研究其粪便胆固醇排泄的可能变化。最明显的效果是在给予鹅去氧胆酸(每天1克)后观察到胆固醇外分泌大量增加(每天234毫克)。这种治疗还倾向于减少膳食胆固醇的吸收并增加胆固醇的排泄。